Cancer Care

Research supports longer zoledronic acid dosing intervals for cancer patients

New research at Christiana Care has the potential to reduce medication side effects and health care costs for certain groups of cancer patients. Researchers at the Helen F. Graham Cancer Center & Research Institute at Christiana Care conducted a randomized clinical trial to determine if administration of zoledronic acid over longer dosing intervals of every […] Read more